Search company, investor...

ADNAvance Technologies

adnavance.com

Founded Year

2002

Stage

Unattributed | Alive

Total Raised

$2.28M

Last Raised

$2M | 17 yrs ago

About ADNAvance Technologies

Adnavance Technologies Inc is developing enabling technology applications that use the conductivity properties of both normal and novel metallic forms of DNA aimed at large biosensormolecular diagnostics and energy generationmanagement markets

Headquarters Location

112B 2386 East Mall

Vancouver, British Columbia, V6T1Z3,

Canada

604-827-5597

Missing: ADNAvance Technologies's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: ADNAvance Technologies's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

ADNAvance Technologies Frequently Asked Questions (FAQ)

  • When was ADNAvance Technologies founded?

    ADNAvance Technologies was founded in 2002.

  • Where is ADNAvance Technologies's headquarters?

    ADNAvance Technologies's headquarters is located at 112B 2386 East Mall, Vancouver.

  • What is ADNAvance Technologies's latest funding round?

    ADNAvance Technologies's latest funding round is Unattributed.

  • How much did ADNAvance Technologies raise?

    ADNAvance Technologies raised a total of $2.28M.

  • Who are the investors of ADNAvance Technologies?

    Investors of ADNAvance Technologies include GrowthWorks, BDC Venture Capital, University Medical Discoveries, Lumira Ventures, Canadian Medical Discoveries Fund and 5 more.

  • Who are ADNAvance Technologies's competitors?

    Competitors of ADNAvance Technologies include BioMarker Strategies, Integrated Nano-Technologies, Ativa Medical, Foundation Medicine, T2 Biosystems and 13 more.

Compare ADNAvance Technologies to Competitors

C
CyberGene

CyberGene manufactures custom oligos, ChromoQuant QF-PCR kit for In Vitro Diagnostics and performes DNA sequencing

P
Pria Diagnostics

Pria Diagnostics specializes in low cost, high performance, fluorescent readers based on Pria's NanoFL platform technology. The company forms partnerships with diagnostics companies and manufacturers, enabling them to improve their current test sensitivity, or to create diagnostics solutions for the point of care market. Pria can help users' business expand into the new and rapidly growing segments of diagnostics testing including, per the company, retail clinics, field testing, physician office laboratories, consumer-driven testing. NanoFL is a proven technology which has been commercialized in Pria's first product, the Element home fertility test for men.

P
Progentech

Molecular diagnostics device company developing automated instruments for nucleic acid purification (NAP) and nucleic acid testing (NAT). The company's first fully-integrated NAP system, the PGT 328, increases the efficiency and quality of nucleic acid purification using ProGenTech's designed disposable cartridges.

Akonni Biosystems Logo
Akonni Biosystems

Akonni Biosystems is a molecular diagnostics (MDx) company that develops, manufactures, and markets integrated molecular diagnostic systems.

Sober Steering Logo
Sober Steering

Sober Steering develops transdermal technologies as means for detecting driver intoxication.

Esaote Logo
Esaote

Esaote is a producer of medical diagnostic systems, including ultrasound and MRI equipment.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.